Ignite Creation Date:
2024-05-06 @ 8:17 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06324760
Status:
COMPLETED
Last Update Posted:
2024-03-22
First Post:
2024-03-12
Brief Title:
Alpha-lipoic Acid Combined With B Vitamins Shows Promise for Treating Restless Legs Syndrome
Sponsor:
Uriach Consumer Healthcare
Organization:
Uriach Consumer Healthcare
Study Overview
Official Title:
Usefulness of Alpha-lipoic Acid Combined With B Vitamins for the Treatment of Restless Legs Syndrome
Status:
COMPLETED
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Investigating Tiobec 400s efficacy in alleviating Restless Legs Syndrome symptoms sheds light on promising therapeutic avenues
Detailed Description:
Restless legs syndrome also known as Willis-Ekbom disease is a neurological disorder characterised by uncomfortable sensations in the legs and an urge to move them In Spain its prevalence range is estimated to be between 116 - 195 in adults but it is difficult to know due to underdiagnosis Alpha-lipoic acid ALA and B vitamins have emerged as potential treatments due to their roles in reducing oxidative stress and associated vitamin deficiencies The Tiobec 400 T400 supplement combines ALA B vitamins E and C and its efficacy and safety in alleviating RLS symptoms along with its impact on anthropometric measures are under investigation This study aims to explore therapeutic options for managing RLS with promising results
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None